Evaluation of <sup>18</sup>F-FMISO PET and <sup>18</sup>F-FDG PET Scans in Assessing the Therapeutic Response of Patients With Metastatic Colorectal Cancer Treated With Anti-Angiogenic Therapy.

Front Oncol · 2021 · PMC8010243 · PMID 33816239

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Following treatment with bevacizumab, changes in FMISO TNR showed a correlation with progression free and overall survival, although this did not reach statistical significance.

also in 111,027 other papers

a trend towards significanceno p-value reported

However, the survival curves for the post-treatment FMISO TNR did demonstrate a trend towards significance, with p-value of 0.16 for PFS and 0.14 for OS ( Figures 4A, B ).

also in 2,760 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.